Rubryc Therapeutics

Developer of antibody-based drugs for treating cancer

placeSan Ramon, California, United States calendar_todayFounded 2018 groups14 employees language rubryc.com

Registered entities

Innovation

5 patent families — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 47 times.

YearFilings
20203
20213
20225
20232

Social engagement

Social engagement: 12.6K social following, 6 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; lead investors include Third Point Ventures, iBio, Hayan Health Networks.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Recent activity

2 Jun 2026
Milestone
regulatory
14 May 2026
Leadership hire
Vice President, Research & Early Development
11 May 2026
Leadership hire
Board of Directors
Coming soon